ASH 2023 Efficacy of Brexu-cel in the treatment of high risk R/R MCL patients Admin January 8, 2024 In this presentation, data sourced from the CIBM-TR registry were utilized to...
ASH 2023 Patient-Reported Outcomes in the QuANTUM-First Trial: Quizartinib Versus Standard Chemotherapy in FLT3-ITD AML patients Admin January 4, 2024 At the ASH meeting, Professor Oliva presented the patient-reported outcomes...